These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26910244)

  • 1. Antigen expression on a putative leukemic stem cell population and AML blast.
    Garg S; Ghosh K; Madkaikar M
    Int J Hematol; 2016 May; 103(5):567-71. PubMed ID: 26910244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential antigen expression and aberrant signaling via PI3/AKT, MAP/ERK, JAK/STAT, and Wnt/β catenin pathways in Lin-/CD38-/CD34+ cells in acute myeloid leukemia.
    Garg S; Shanmukhaiah C; Marathe S; Mishra P; Babu Rao V; Ghosh K; Madkaikar M
    Eur J Haematol; 2016 Mar; 96(3):309-17. PubMed ID: 26010294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.
    Al-Mawali A; Gillis D; Lewis I
    J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD90, CD96, CD117, and CD123 on different hematopoietic cell populations from pediatric patients with acute myeloid leukemia.
    Chávez-González A; Dorantes-Acosta E; Moreno-Lorenzana D; Alvarado-Moreno A; Arriaga-Pizano L; Mayani H
    Arch Med Res; 2014 May; 45(4):343-50. PubMed ID: 24751333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The immunophenotypic analysis of CD7+ and (or) CD56+ acute myeloid leukemic stem cells and its applications in minimal residual disease detection].
    Cao H; Wang YZ; Wu HH; Chang Y; Hao L; Chen SS; Huang XJ; Lu DP; Liu YR
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jan; 29(1):23-8. PubMed ID: 18512311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD34+CD38-CD123+ Cells Are Present in Virtually All Acute Myeloid Leukaemia Blasts: A Promising Single Unique Phenotype for Minimal Residual Disease Detection.
    Al-Mawali A; Pinto AD; Al-Zadjali S
    Acta Haematol; 2017; 138(3):175-181. PubMed ID: 29065396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High proportion of leukemic stem cells at diagnosis is correlated with unfavorable prognosis in childhood acute myeloid leukemia.
    Witte KE; Ahlers J; Schäfer I; André M; Kerst G; Scheel-Walter HG; Schwarze CP; Pfeiffer M; Lang P; Handgretinger R; Ebinger M
    Pediatr Hematol Oncol; 2011 Mar; 28(2):91-9. PubMed ID: 21214408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD45
    Heo SK; Noh EK; Ju LJ; Sung JY; Jeong YK; Cheon J; Koh SJ; Min YJ; Choi Y; Jo JC
    BMC Cancer; 2020 Apr; 20(1):285. PubMed ID: 32252668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of molecular targets on the surface of CD34+CD38- bone marrow cells in myelodysplastic syndromes.
    Xie W; Wang X; Du W; Liu W; Qin X; Huang S
    Cytometry A; 2010 Sep; 77(9):840-8. PubMed ID: 20662087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric quantification and immunophenotyping of leukemic stem cells in acute myeloid leukemia.
    Hwang K; Park CJ; Jang S; Chi HS; Kim DY; Lee JH; Lee JH; Lee KH; Im HJ; Seo JJ
    Ann Hematol; 2012 Oct; 91(10):1541-6. PubMed ID: 22669506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRP1 protein expression in leukemic stem cells as a negative prognostic marker in acute myeloid leukemia patients.
    Paprocka M; Bielawska-Pohl A; Rossowska J; Krawczenko A; Duś D; Kiełbiński M; Haus O; Podolak-Dawidziak M; Kuliczkowski K
    Eur J Haematol; 2017 Nov; 99(5):415-422. PubMed ID: 28805931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant marker expression patterns on the CD34+CD38- stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission.
    van Rhenen A; Moshaver B; Kelder A; Feller N; Nieuwint AW; Zweegman S; Ossenkoppele GJ; Schuurhuis GJ
    Leukemia; 2007 Aug; 21(8):1700-7. PubMed ID: 17525725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Flow cytometric characterization of maturation processes and primitive stem cell population in pre-B-cell ALL in childhood].
    Baersch G; Baumann M; Meltzer J; Möllers T; Ritter J; Jürgens H; Vormoor J
    Klin Padiatr; 1996; 208(4):160-7. PubMed ID: 8926682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunophenotyping of leukemic stem cells and chromosome karyotype characteristics in Uyghur leukemia pediatric patients].
    Hailiqiguli N; Yan M
    Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):501-4. PubMed ID: 24257300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotypic characterization of leukemic stem cells in acute myeloid leukemia using single tube 10-colour panel by multiparametric flow cytometry: Deciphering the spectrum, complexity and immunophenotypic heterogeneity.
    Das N; Panda D; Gajendra S; Gupta R; Thakral D; Kaur G; Khan A; Singh VK; Vemprala A; Bakhshi S; Seth R; Sahoo RK; Sharma A; Rai S; Prajapati VK; Singh S
    Int J Lab Hematol; 2024 Aug; 46(4):646-656. PubMed ID: 38456256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a hierarchy in human acute myeloid leukemia progenitor cells.
    Sutherland HJ; Blair A; Zapf RW
    Blood; 1996 Jun; 87(11):4754-61. PubMed ID: 8639846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristic and prognostic significance of leukemia stem cells associated antigens expressions in t (8;21) acute myeloid leukemia].
    Dao FT; Yang L; Wang YZ; Chang Y; Jiang Q; Jiang H; Liu YR; Huang XJ; Qin YZ
    Zhonghua Xue Ye Xue Za Zhi; 2019 Oct; 40(10):831-836. PubMed ID: 31775482
    [No Abstract]   [Full Text] [Related]  

  • 18. High GPR56 surface expression correlates with a leukemic stem cell gene signature in CD34-positive AML.
    Daga S; Rosenberger A; Quehenberger F; Krisper N; Prietl B; Reinisch A; Zebisch A; Sill H; Wölfler A
    Cancer Med; 2019 Apr; 8(4):1771-1778. PubMed ID: 30848055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemic stem cell frequency: a strong biomarker for clinical outcome in acute myeloid leukemia.
    Terwijn M; Zeijlemaker W; Kelder A; Rutten AP; Snel AN; Scholten WJ; Pabst T; Verhoef G; Löwenberg B; Zweegman S; Ossenkoppele GJ; Schuurhuis GJ
    PLoS One; 2014; 9(9):e107587. PubMed ID: 25244440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations.
    Haase D; Feuring-Buske M; Könemann S; Fonatsch C; Troff C; Verbeek W; Pekrun A; Hiddemann W; Wörmann B
    Blood; 1995 Oct; 86(8):2906-12. PubMed ID: 7579382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.